We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

ICON Creates New Global Innovation Hub in Ireland

News   Feb 05, 2015

 
ICON Creates New Global Innovation Hub in Ireland
 
 
Advertisement
 

RELATED ARTICLES

NIH Closes Enrolment for Two Sub-Studies in ACTIV-3 Trial

News

The ACTIV-3 clinical trial, which is evaluating the safety and efficacy of investigational therapeutics for COVID-19 in hospitalized patients, has closed enrolment in two sub-studies. The first sub-study was examining the investigational monoclonal antibody therapy VIR-7831 and the second was evaluating a combined monoclonal antibody therapy containing BRII-196 and BRII-198.

READ MORE

Nanoparticle-Infused Contact Lenses Correct Color Blindness

News

Dyed contact lenses currently in development for color blindness are potentially harmful and unstable. Now, researchers have infused contact lenses with gold nanoparticles to create a safer way to see colors.

READ MORE

Drug Shown To Help Diabetes Patients Lose Weight in Clinical Study

News

In a multicenter Phase 3 clinical study, the drug semaglutide was shown to help patients with diabetes lose on average 10 to 17% of their body weight.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE